Neoadjuvant GOLP Improves Outcomes in High-Risk Cholangiocarcinoma
Neoadjuvant GOLP therapy significantly enhances event-free survival in patients with resectable high-risk intrahepatic cholangiocarcinoma.
Newsletter
Best Papers in General Surgery
The five that matter, every day.
Neoadjuvant GOLP therapy significantly enhances event-free survival in patients with resectable high-risk intrahepatic cholangiocarcinoma.
Surgeons need to know that 39% of countries provide timely access to essential surgery, underscoring a significant global shortfall in surgical care.
Endoscopic ultrasound-guided gastrojejunostomy (eus-gj) outperforms surgical methods for malignant gastric outlet obstruction, impacting patient outcomes.
Neoadjuvant chemotherapy does not improve disease-free survival compared to upfront surgery for locally advanced colon cancer, but shows benefits in feasibility and reduced need for adjuvant therapy.
Medicaid expansion improves survival and surgical access for pancreatic cancer patients.
taTME shows promising long-term outcomes for low rectal cancer patients, crucial for surgical practice.
Using synthetic mesh for parastomal hernia repair reduces long-term recurrence risk compared to biologic mesh, which is crucial for surgical decision-making.
Transplanting liver patients who respond to atezolizumab-bevacizumab is promising for those with intermediate and advanced hepatocellular carcinoma.
Silent video can predict surgeons' non-technical skills, impacting training and outcomes.
This study assessed shared decision-making among thousands of surgeons, revealing critical insights for improving patient outcomes.